Oncology evaluation directory Urologic oncology

Kidney Cancer Evaluation

A renal cancer review focused on pathology subtype, nephrectomy status, metastatic pattern, kidney function, IMDC-style risk features, prior immunotherapy or targeted therapy and treatment tolerance.

RCC subtypeKidney functionIO/TKI history
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic

What the specialist needs to understand before any treatment discussion.

Kidney cancer evaluation begins with subtype. Clear cell RCC, non-clear cell RCC and other renal tumors can require different review logic. Kidney function and prior nephrectomy status are also central to safety planning.

The file must show current disease burden, symptoms and prior immunotherapy/targeted therapy exposure before any international specialist discussion is useful.

01

Pathology subtype

Clear cell RCC, papillary, chromophobe or another subtype should be identified.

02

Surgery status

Partial/radical nephrectomy, biopsy, margins and complications are documented.

03

Metastatic pattern

Lung, bone, liver, brain, adrenal or nodal disease is summarized with recent imaging.

04

Risk and labs

Hemoglobin, calcium, neutrophils/platelets, kidney/liver function and performance status are reviewed.

05

Prior systemic therapy

Immunotherapy combinations, TKIs, mTOR inhibitors or other therapies are listed by date and response.

06

Symptoms and safety

Hematuria, pain, bone lesions, brain symptoms and kidney function risks are documented.

Evaluation matrix

How the case is reviewed without reducing it to a diagnosis name.

Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.

01

Subtype matters

Non-clear cell disease should not be assumed to follow the same path as clear cell RCC.

02

Renal function

Single kidney status and creatinine/eGFR affect safety and travel planning.

03

Metastatic burden

Bone or brain involvement may require urgent local management.

04

Therapy tolerance

Hypertension, diarrhea, immune side effects and fatigue affect sequencing.

Documents to prepare

A complete medical file prevents delay and unrealistic expectations.

Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.

PathologyBiopsy/nephrectomy pathology and subtype.
Surgery recordsOperative report, margins and postoperative complications.
ImagingCT/MRI/PET/bone/brain imaging reports as relevant.
Laboratory panelCBC, creatinine/eGFR, liver function, calcium and inflammatory markers.
Treatment timelineImmunotherapy, TKI and other treatments with response/toxicity.
Current oncology noteLatest assessment and clinical question.
Cuba context

How Cuba-related options are framed responsibly.

The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.

01

Safety before travel

Kidney function and symptomatic metastases must be understood first.

02

Systemic history is essential

Prior immunotherapy/targeted therapy exposure changes specialist interpretation.

03

Coordinated review only

CHA prepares the case; the physician determines what is medically reasonable.

When local care comes first

Do not wait for international review if urgent symptoms are present.

International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.

  • New neurological symptoms, severe headache or seizures.
  • Severe bone pain, weakness or suspected fracture/spinal compression.
  • Heavy blood in urine, kidney failure symptoms or uncontrolled high blood pressure.
Coordination pathway

From records to written next steps.

  1. File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
  2. Quality checkThe coordination team checks readability, dates, translation needs and missing items.
  3. Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
  4. Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions

Before starting the application.

Does this page mean I am suitable for a Cuba-based treatment?

No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.

Can I send only a short summary?

A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.

Will the coordinator choose my treatment?

No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.

What happens if my file is incomplete?

The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.

Can urgent symptoms be handled through this page?

No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.

Start with the file

Submit documents before making a travel or treatment decision.

A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.